Halminen J, Sattaer N, Rawshani A et al (2022) Range of risk factor levels, risk control, and temporal trends for nephropathy and end-stage kidney disease in patients with type 1 and type 2 diabetes
Material discussed here is intended for laboratory research use only and is not for human or veterinary use
Beyond its glucose-lowering effects, Ozempic has been shown to promote weight loss in many patients, which can be particularly beneficial for individuals with type 2 diabetes who are overweight or obese
Certain individuals with specific genetic conditions face genuine elevated risk and absolutely should avoid these medications
If you are looking for a product for personal or cosmetic use, this is not one, and we will not supply it on that basis
Light, medium, green or white is best, and it must be caffeinated